Emile Van Schaftingen

21.0k total citations · 2 hit papers
263 papers, 15.6k citations indexed

About

Emile Van Schaftingen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry. According to data from OpenAlex, Emile Van Schaftingen has authored 263 papers receiving a total of 15.6k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Molecular Biology, 77 papers in Endocrinology, Diabetes and Metabolism and 65 papers in Clinical Biochemistry. Recurrent topics in Emile Van Schaftingen's work include Metabolism, Diabetes, and Cancer (74 papers), Diet, Metabolism, and Disease (72 papers) and Pancreatic function and diabetes (62 papers). Emile Van Schaftingen is often cited by papers focused on Metabolism, Diabetes, and Cancer (74 papers), Diet, Metabolism, and Disease (72 papers) and Pancreatic function and diabetes (62 papers). Emile Van Schaftingen collaborates with scholars based in Belgium, France and United States. Emile Van Schaftingen's co-authors include H G Hers, Maria Veiga‐da‐Cunha, Carole L. Linster, Isabelle Gerin, Louis Hue, Jaak Jaeken, A. Vandercammen, Vincent Stroobant, Ramón Bartrons and Didier Vertommen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Emile Van Schaftingen

262 papers receiving 15.1k citations

Hit Papers

A Kinetic Study of Pyrophosphate: Fructose‐6‐Phosphate Ph... 1982 2026 1996 2011 1982 2006 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Kinetic Study of Pyrophosphate: Fructose‐6‐Phosphate Phosphotransferase from Potato Tubers
    1982 585 citations Emile Van Schaftingen, H G Hers et al. European Journal of Biochemistry profile →
  2. Vitamin C
    2006 578 citations Emile Van Schaftingen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emile Van Schaftingen Belgium 68 9.8k 2.9k 2.8k 2.3k 2.3k 263 15.6k
José M. Mato Spain 75 10.3k 1.1× 1.8k 0.6× 1.6k 0.6× 2.0k 0.9× 1.7k 0.7× 371 18.6k
Dennis E. Vance Canada 69 8.5k 0.9× 2.7k 0.9× 2.1k 0.7× 922 0.4× 3.1k 1.3× 238 16.4k
Janardan K. Reddy United States 78 15.2k 1.6× 2.0k 0.7× 1.6k 0.6× 3.3k 1.4× 4.5k 1.9× 333 22.4k
Rosalind Coleman United States 68 8.6k 0.9× 2.0k 0.7× 1.4k 0.5× 1.4k 0.6× 4.3k 1.9× 197 15.3k
H G Hers Belgium 67 6.6k 0.7× 2.7k 0.9× 2.8k 1.0× 1.9k 0.8× 2.9k 1.2× 159 12.3k
Nada A. Abumrad United States 75 9.5k 1.0× 3.2k 1.1× 2.4k 0.9× 2.3k 1.0× 5.4k 2.4× 179 18.4k
John H. Exton United States 90 18.0k 1.8× 4.5k 1.5× 2.7k 1.0× 968 0.4× 5.8k 2.5× 275 27.1k
John Turk United States 73 8.5k 0.9× 3.2k 1.1× 1.8k 0.6× 702 0.3× 2.9k 1.3× 267 15.5k
Philip W. Majerus United States 88 11.3k 1.2× 2.4k 0.8× 1.0k 0.4× 1.3k 0.5× 1.9k 0.8× 231 22.9k
Akira Yoshida Japan 57 5.4k 0.5× 1.3k 0.4× 1.7k 0.6× 821 0.4× 2.0k 0.9× 507 12.6k

Countries citing papers authored by Emile Van Schaftingen

Since Specialization
Citations

This map shows the geographic impact of Emile Van Schaftingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emile Van Schaftingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emile Van Schaftingen more than expected).

Fields of papers citing papers by Emile Van Schaftingen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emile Van Schaftingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emile Van Schaftingen. The network helps show where Emile Van Schaftingen may publish in the future.

Co-authorship network of co-authors of Emile Van Schaftingen

This figure shows the co-authorship network connecting the top 25 collaborators of Emile Van Schaftingen. A scholar is included among the top collaborators of Emile Van Schaftingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emile Van Schaftingen. Emile Van Schaftingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kentache, Takfarinas, Erika Souche, Céline Schulz, et al.. (2024). Absence of the dolichol synthesis gene DHRSX leads to N-glycosylation defects in Lec5 and Lec9 Chinese hamster ovary cells. Journal of Biological Chemistry. 300(12). 107875–107875. 2 indexed citations
2.
Veiga‐da‐Cunha, Maria, Saskia B. Wortmann, Sarah C. Grünert, & Emile Van Schaftingen. (2023). Treatment of the Neutropenia Associated with GSD1b and G6PC3 Deficiency with SGLT2 Inhibitors. Diagnostics. 13(10). 1803–1803. 19 indexed citations
3.
Chevalier, Nathalie, et al.. (2023). SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia. Cellular and Molecular Life Sciences. 80(9). 259–259. 12 indexed citations
4.
Gladyshev, Vadim N., Stephen B. Kritchevsky, Steven Clarke, et al.. (2021). Molecular damage in aging. Nature Aging. 1(12). 1096–1106. 90 indexed citations
5.
Machelart, Arnaud, Kévin Willemart, Amaia Zúñiga-Ripa, et al.. (2020). Convergent evolution of zoonotic Brucella species toward the selective use of the pentose phosphate pathway. Proceedings of the National Academy of Sciences. 117(42). 26374–26381. 14 indexed citations
6.
Wortmann, Saskia B., Johan L.K. Van Hove, Terry G. J. Derks, et al.. (2020). Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor. Blood. 136(9). 1033–1043. 93 indexed citations
7.
Dewulf, Joseph P., Elsa Wiame, Imen Dorboz, et al.. (2019). SLC13A3 variants cause acute reversible leukoencephalopathy and α‐ketoglutarate accumulation. Annals of Neurology. 85(3). 385–395. 19 indexed citations
8.
Park, Julien H., Marianne Grüneberg, Stephan Rust, et al.. (2017). Limitations of galactose therapy in phosphoglucomutase 1 deficiency. Molecular Genetics and Metabolism Reports. 13. 33–40. 27 indexed citations
9.
Veiga‐da‐Cunha, Maria, Nathalie Chevalier, Vincent Stroobant, Didier Vertommen, & Emile Van Schaftingen. (2014). Metabolite Proofreading in Carnosine and Homocarnosine Synthesis. Journal of Biological Chemistry. 289(28). 19726–19736. 32 indexed citations
10.
Demaegd, Didier, François Foulquier, Dominique Legrand, et al.. (2013). Newly characterized Golgi-localized family of proteins is involved in calcium and pH homeostasis in yeast and human cells. Proceedings of the National Academy of Sciences. 110(17). 6859–6864. 118 indexed citations
11.
Kranendijk, Martijn, Gajja S. Salomons, K. Michael Gibson, et al.. (2011). A lymphoblast model for IDH2 gain-of-function activity in d-2-hydroxyglutaric aciduria type II: Novel avenues for biochemical and therapeutic studies. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(11). 1380–1384. 12 indexed citations
12.
Veiga‐da‐Cunha, Maria, et al.. (2008). Mammalian Phosphomannomutase PMM1 Is the Brain IMP-sensitive Glucose-1,6-bisphosphatase. Journal of Biological Chemistry. 283(49). 33988–33993. 32 indexed citations
13.
Vertommen, Didier, et al.. (2005). Identification of the sequence encoding N-acetylneuraminate-9-phosphate phosphatase. Glycobiology. 16(2). 165–172. 36 indexed citations
14.
Matthijs, Gert, et al.. (2000). Partial deficiency of phosphomannomutase: a pitfall in the diagnosis of congenital disorders of glycosylation (CDG-Ia). The American Journal of Human Genetics. 67(4). 36–36. 1 indexed citations
15.
Matthijs, Gert, Els Schollen, Jaak Jaeken, Emile Van Schaftingen, & JJ Cassiman. (1997). Exhaustive mutation analysis of the PMM2 gene in patients with the carbohydrate-deficient glycoprotein syndrome type I (CDG1 or Jaeken syndrome) and cloning of the mouse Pmm1 and Pmm2 genes.. The American Journal of Human Genetics. 61(4).
16.
Veiga‐da‐Cunha, Maria, et al.. (1996). Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein. Diabetologia. 39(10). 1173–1179. 32 indexed citations
17.
Malaisse, Willy, F Malaisse-Lagae, Dewi R. Davies, & Emile Van Schaftingen. (1989). Presence of fructokinase in pancreatic islets. FEBS Letters. 255(1). 175–178. 21 indexed citations
18.
François, Jean, Emile Van Schaftingen, & H G Hers. (1988). Characterization of phosphofructokinase 2 and of enzymes involved in the degradation of fructose 2,6‐bisphosphate in yeast. European Journal of Biochemistry. 171(3). 599–608. 49 indexed citations
19.
Sener, Abdullah, Emile Van Schaftingen, M. Van De Winkel, et al.. (1984). Effects of glucose and glucagon on the fructose 2,6-bisphosphate content of pancreatic islets and purified pancreatic B-cells. A comparison with isolated hepatocytes. Biochemical Journal. 221(3). 759–764. 27 indexed citations
20.
Malaisse, Willy, et al.. (1981). Glucose-induced activation of phosphofructokinase in pancreatic islets. Diabetes. 30. 115. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José M. Mato Breakdown of academic impact, for papers by Dennis E. Vance Breakdown of academic impact, for papers by Janardan K. Reddy Breakdown of academic impact, for papers by Rosalind Coleman Breakdown of academic impact, for papers by H G Hers Breakdown of academic impact, for papers by Nada A. Abumrad Breakdown of academic impact, for papers by John H. Exton Breakdown of academic impact, for papers by John Turk Breakdown of academic impact, for papers by Philip W. Majerus Breakdown of academic impact, for papers by Akira Yoshida
Rankless by CCL
2026